triumph-3 retatrutide approval: FDA status, clinical trial results, and when it could be available Retatrutide hits 28.3% weight loss

Macarulla, M

That's the end goal."Chandler also suggested consulting a healthcare provider if there are noticeable changes in weight, diet, or exercise patterns

While taking the prescription, hunger decreases, which causes the individual to eat less, and lose weight

Evidence for the adverse effect of starvation on bone quality: A review of the literature

Practical Recommendations for Clinicians Given the inconclusive data on bone safety during GLP1 treatment, clinicians should: Assess fracture risk using tools like FRAX before starting therapy Order BMD tests for patients with osteoporosis risk factors Monitor for excessive or rapid weight loss that may compromise bone mass Promote calcium and vitamin D intake, resistance training, and fall prevention strategies Refer to endocrinologists or bone specialists as needed for complex cases Future Research Questions Several questions remain unanswered about how GLP1 medications influence longterm bone integrity: Do individual GLP1 agents differ in their effects on bone remodeling